Literature DB >> 6780982

Quantum chemical calculation of the (S)-9-(2,3-dihydroxypropyl)adenine molecule.

Z Havlas, H Hrebabecký, J Beránek.   

Abstract

Quantum chemical calculations of conformational maps of the molecule of a new virostatic agent (S)-9-(2,3-dihydroxypropyl)adenine were performed. The thermodynamically most advantageous conformation I corresponds, for the D-series, to the alpha-ribo configuration, while the following minima, which are close in energy (II,III), correspond to beta-ribo and beta-xylo configurations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6780982      PMCID: PMC328085          DOI: 10.1093/nar/8.24.6233

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  8 in total

1.  (S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity.

Authors:  E DE Clercq; J Descamps; P DE Somer; A Holyacute
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

2.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

Review 3.  The crystal structures of purines, pyrimidines and their intermolecular complexes.

Authors:  D Voet; A Rich
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1970

4.  A novel method for the synthesis of purine alpha-ribonucleosides.

Authors:  Y Furukawa; K Imai; M Honjo
Journal:  Tetrahedron Lett       Date:  1968-09       Impact factor: 2.415

5.  Novel substrate of adenosine deaminase.

Authors:  H J Schaeffer; S Gurwara; R Vince; S Bittner
Journal:  J Med Chem       Date:  1971-04       Impact factor: 7.446

6.  Syntheses of alpha- and beta-adenosine and of alpha- and beta-2'-deoxyadenosine with phenyl polyphosphate.

Authors:  G Schramm; G Lünzmann; F Bechmann
Journal:  Biochim Biophys Acta       Date:  1967-09-26

7.  HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

Authors:  R G Chadwick; M F Bassendine; E M Crawford; H C Thomas; S Sherlock
Journal:  Br Med J       Date:  1978-08-19

Review 8.  Aranucleosides and aranucleotides in viral chemotherapy.

Authors:  T W North; S S Cohen
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.